Orion Portfolio Solutions’s Xenon Pharmaceuticals XENE Stock Holding History

Orion Portfolio Solutions’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$521K	Buy	15,531 +2,095	+16%	+$79.5K	0.01%	1406
2024 Q4	$527K	Sell	13,436 -1,067	-7%	-$44.1K	0.01%	1333
2024 Q3	$571K	Sell	14,503 -11	-0.1%	-$444	0.01%	1288
2024 Q2	$566K	Buy	14,514 +816	+6%	+$32.6K	0.01%	1235
2024 Q1	$590K	Buy	13,698 +5,481	+67%	+$252K	0.01%	1198
2023 Q4	$393K	Sell	8,217 -7,185	-47%	-$254K	﹤0.01%	1301
2023 Q3	$526K	Sell	15,402 -404	-3%	-$15.1K	0.01%	1187
2023 Q2	$609K	Buy	+15,806	New	+$628K	0.01%	1148

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Orion Portfolio Solutions's XENE Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Xenon Pharmaceuticals (XENE) stake by 16% in Q1 2025, buying an estimated $79.5K and bringing the position to 15,531 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #1406.

Orion Portfolio Solutions first reported a position in XENE in Q2 2023 and has held it in 8 quarters since. The position peaked at $609K in Q2 2023. 206 funds tracked by Wall St. Rank hold XENE as of Q1 2025.

Orion Portfolio Solutions held 15,531 shares of Xenon Pharmaceuticals worth $521K as of Q1 2025.
Orion Portfolio Solutions bought 2,095 Xenon Pharmaceuticals shares in Q1 2025, an estimated $79.5K.
Xenon Pharmaceuticals made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1406 holding.
Orion Portfolio Solutions first reported a position in Xenon Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
Orion Portfolio Solutions's Xenon Pharmaceuticals position peaked at $609K in Q2 2023.
206 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.